logo

IPO

Share

Accolade, Inc. announced pricing of initial public offering of 10.02 million common shares at $22.00 per share, above the estimated range. The company expects offering to close on July 7, 2020. The company has originally filed to sell 8.75 million shares at a range of $19 to $21 share. Accolade...

nasdaq july01 Seattle, Washington-based Accolade Inc. is scheduled to list its IPO on the Nasdaq Global Select Market under the symbol "ACCD" on July 2, 2020. The initial public offering price is expected to be between $19.00 and $21.00 per share.

Dun & Bradstreet Holdings Inc. said that it has priced its initial public offering of 78.30 million shares at price of $22.00 per share. The shares are expected to begin trading on the New York Stock Exchange on July 1, 2020 under the symbol "DNB." The initial public offering is expected to close...

Akouos, Inc. (AKUS) announced the pricing of initial public offering of 12.5 million shares at $17.00 per share for gross proceeds of $212.5 million. The offering is expected to close on or about June 30, 2020. Earlier on Thursday, Akouos filed an amendment and the size of the IPO was increased to...

Lemonade, Inc. said the company is offering 11 million shares of common stock under its initial public offering. The initial public offering is expected to be between $23.00 and $26.00 per share. The shares are expected to trade on the New York Stock Exchange under the ticker symbol, LMND. Lemonade...

akouos june25 The IPO activity in the U.S. pharma/biotech sector has had a strong showing in the month of June, with 14 listings so far. Now, let's take a look at the biotech IPOs scheduled for Friday, June 26, 2020.

Forma Therapeutics Holdings, Inc. (FMTX) announced the pricing of initial public offering of 13.88 million shares at $20.00 per share, above the expected range of $16 to $18. The offering is expected to close on June 23, 2020. The company has originally planned to offer 11.76 million shares of its...

Repare Therapeutics Inc. (RPTX) announced the pricing of upsized initial public offering of 11 million common shares at $20.00 per share. The offering is expected to close on June 23, 2020. The company has originally filed to sell 7.35 million shares at a range of $16 to $18 share. On July 17, the...

biotechipo june17 The U.S. healthcare sector is seeing a flurry of IPO activity in June. So far this month, 10 companies  have made their stock market debut. Let's take a look at the IPOs slated for tomorrow.

Royalty Pharma plc announced the pricing of initial public offering of 77.68 million shares of Class A ordinary shares at $28 per share, the high end of the expected range of $25 to $28. The offering is expected to close on June 18, 2020. The size of the IPO was increased from the previously announced...

ipo dec23 Royalty Pharma is an acquirer of revenue-producing intellectual property - principally royalty interests in marketed and late stage biopharmaceutical products. The company's portfolio includes royalties on over 45 commercial products, including AbbVie and J&J's Imbruvica, Astellas and Pfizer's Xtandi,...

Avidity Biosciences Inc. (RNA) said that it has priced its initial public offering of 14.40 million shares of common stock at $18.00 per share. The shares are expected to begin trading on the Nasdaq Global Market on June 12, 2020 under the ticker symbol "RNA". The company expects the gross proceeds...

Generation Bio Co.(GBIO) said that it has priced its initial public offering of 10.53 million shares at $19.00 per share. In addition, the company has granted the underwriters a 30-day option to purchase up to 1.58 million additional shares of common stock at the initial public offering price, less...

ipo 0611 The IPO activity in the U.S. healthcare sector is back with a bang this month. Five companies have gone public so far this month. (Inludes Lantern Pharma (LTRN), which is set to begin trading on June 11). Now, let's take a look at the IPOs scheduled for Friday.

vroom june09 Online automotive retailer Vroom, Inc. has priced its initial public offering to raise $465.5 million, which reportedly will give it a market capitalisation of over $2 billion. The New York City-based online marketplace for used cars has priced its 21.25 million shares at a price of $22.00 per share. The price has been raised amid increased demand.

Follow RTT